Palvella Therapeutics to Present Update on PTX-022 at Pachyonychia Congenita Project Patient Support Meeting in London, UK

By WebmasterOctober 19, 2018November 1st, 2024No Comments

Palvella Therapeutics to Present Update on PTX-022 at Pachyonychia Congenita Project Patient Support Meeting in London, UK

Previous PostOncora Medical teams up with oncologists at N.Y.'s largest health system
Next PostMelior Pharmaceuticals Enrolls Last Subject in Phase 2b Study with Tolimidone for Type 2 Diabetes